Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sulzer Medica/Tutogen Medical

This article was originally published in The Gray Sheet

Executive Summary

Sulzer increases stake in bioimplants maker Tutogen through Nov. 17 deal with Capital Partners II, under which Sulzer will purchase up to 50% of beneficiaries' interests in Capital Partners for about $30 mil. (21,627 trust units at $1,387 each). Capital Partners owns more than 50% of Tutogen. Sulzer already has a stake of almost 10% in Tutogen, and markets the firm's bone tissue products for spinal and dental applications. If Sulzer is offered fewer than 8,651 trust units, then the firm will have no obligation to complete the deal, Sulzer notes. Tender offer is valid for at least 20 working days
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT014181

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel